Skip navigation
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Prevention Among Injection Drug Users
 IDU HIV Prevention

Archive archive

 IDU Home
 Fact Sheets:
 Syringe Disinfection
 Sterile Syringes
 Viral Hepatitis
 Subst. Abuse
 Criminal Justice
 Order Printed Materials
 Dear Colleague Letters
 Other Publications
 Safe Community Syringe Disposal
Explore IDU Topics
Link to a PDF document Link to a PDF document
Link to a Non-CDC site
Link to non-CDC site or document and does not necessarily represent the views of CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
U.S. Department of Health and Human Services

Archival Content: 1999-2005

A Comprehensive Approach:
Preventing Blood-Borne Infections Among Injection Drug Users

Chapter 2, Section 4: References

Academy for Educational Development. Comprehensive HIV prevention services for injection drug users: an assessment of state and local technical assistance issues and priorities. Washington (DC): AED; August 1999. Prepared for the Centers for Disease Control and Prevention.

Academy for Educational Development. HIV prevention among drug users: a resource book for community planners and program managers. Washington (DC): Academy for Educational Development; 1997. Funding provided under Centers for Disease Control and Prevention contract number 200-91-0906.

Amaro H. An expensive policy: the impact of inadequate funding for substance abuse treatment. [editorial] American Journal of Public Health 1999;89:657-659.

Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. The International Journal of Drug Policy 1999;10:25-38.

Breitbart V, Chavkin W, Wise P. The accessibility of drug treatment for pregnant women: a survey of programs in five cities. American Journal of Public Health 1994;84(10):1658-1661.

Burris S, Lurie P, Abrahamson D, Rich JD. Physician prescribing of sterile injection equipment to prevent HIV infection: time for action.Link to a Non-CDC Link Annals of Internal Medicine 2000;133:218-226.

California Department of Alcohol and Drug Programs. Evaluating recovery services: The California Drug and Alcohol Treatment Assessment. Sacramento (CA): California Department of Alcohol and Drug Programs; 1994.

Case P, Meehan T, Jones TS. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;18(Suppl 1):S71-S75.

Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. American Journal of Psychiatry 1999;156(1):11-18.

Cole FL, Slocumb EM. Nurses' attitudes toward patients with AIDS. Journal of Advanced Nursing 1993;18:1112-1117.

Des Jarlais DC, Friedman SR, Ward TP. Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annual Reviews of Public Health 1993;14:413-450.

Epstein J, Gfroerer J. Changes affecting NHSDA estimates of treatment need for 1994-1996.Link to a Non-CDC Link Rockville (MD): Office of Applied Studies, Substance Abuse and Mental Health Services Administration, January 1998.

Friedman SR. The political economy of drug-user scapegoating-and the philosophy and politics of resistance. Drugs: Education, Prevention, and Policy 1998;5(1):15-32.

Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18(Suppl 1):S60-S70.

Jones TS, Anderson T. "Junkiephobia": a new concept to capture the stigma and ostracism of drug users and limitations on HIV prevention for drug users. Poster presented at National HIV Prevention Conference, Atlanta (GA), August 29-September 1, 1999.

Jones TS, Taussig J. Should pharmacists sell sterile syringes to injection drug users? Journal of the American Pharmaceutical Association 1999;39(1):8-10.

Koester SK. Copping, running, and paraphernalia laws: contextual and needle risk behavior among injection drug users in Denver. Human Organization 1994;53:287-295.

Koob GF. Drugs of abuse: anatomy, pharmacology, and function of reward pathways. Trends in Pharmacological Sciences. 1992;13:177-184.

Koob GF. Drug addiction: the yin and yang of hedonic homeostatis. Neuron. 1996;16(5):893-896.

Leshner A. Why shouldn't society treat substance abusers? Los Angeles Times. June 11, 1999.

Leshner AI. Addiction is a brain disease and it matters. Science 1997;278:45-47.

Lorvick J, Bluthenthal R, Kral AH. The withdrawal of SSI disability benefits for drug and alcohol addiction.Link to a Non-CDC Link Harm Reduction Communication New York (NY): New York Harm Reduction Educators, Inc; Fall 1997.

McGrory BJ, McDowell DM, Muskin PR. Medical students' attitudes toward AIDS, homosexual, and intravenous drug-abusing patients: a re-evaluation in New York City. Psychosomatics 1990;31(4):426-433.

National Institute on Drug Abuse (NIDA) and Hospital Practice. New understanding of drug addiction. Proceedings from a symposium cosponsored by the National Institute on Drug Abuse (NIDA) and Hospital Practice. Minneapolis (MN): McGraw Hill Healthcare Information Programs; April 1997.

National Institutes of Health (NIH). Effective medical treatment of opiate addiction. NIH Consensus Statement. 1997, November 17-19;15(6):1-38.

O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet 1996;347:237-240.

Rydell CP, Everingham SMS. Controlling cocaine: supply versus demand programs. Santa Monica (CA): RAND Corporation; 1994.

U.S.General Accounting Office (GAO). Women in prison: issues and challenges confronting U.S. correctional systems. Washington (DC):GAO; 1999. GAO Report No.:GGD-00-22. www.gao.govLink to a Non-CDC Link

U.S. House of Representatives. Prohibiting the expenditure of federal funds for distribution of needles or syringes for hypodermic injection of illegal drugs. Congressional Record-House. April 29, 1998, H2445-H2478.

Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schulyer D, Dewey S, Wolf AP. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993;14:169-177.

Wallack JJ. AIDS and the health care professional: evolving attitudes and strategies to effect change. Psychiatric Medicine 1991;9(3):483-501.

Wren C. Top U.S. drug official proposes shift in criminal justice policy. The New York Times. December 9, 1999.

Yedidia MJ, Barr, JK, Berry CA. Physicians' attitudes toward AIDS at different career stages:a comparison of internists and surgeons. Journal of Health and Social Behavior 1993;34:272-284.

Yedidia MJ, Berry CA, Barr, JK. Physicians' attitudes toward AIDS during residency training: a longitudinal study of medical school graduates. Journal of Health and Social Behavior 1996;37:179-191.

View PDFPDF Icon

Previous Page | Table of Contents | Next Page

This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content.

Go to top

Privacy Policy | Accessibility The U.S. Government's Official Web Portal